Prevention of human papillomavirus-related malignancy: Access is the answer

Authors

  • Linda R. Duska MD,

    Corresponding author
    1. Department of Obstetrics and Gynecology, University of Virginia Health Systems, Charlottesville, Virginia
    • Corresponding author: Linda R. Duska, MD, University of Virginia, Department of Obstetrics and Gynecology, PO Box 800712, Charlottesville VA 22908; Fax: (434) 982-1580; lduska@virginia.edu

    Search for more papers by this author
  • Mark H. Stoler MD

    1. Department of Surgical Pathology, University of Virginia Health Systems, Charlottesville, Virginia
    Search for more papers by this author

Abstract

The majority of HPV-related cancers are caused by HPV 16 and HPV 18, but the distribution of these two viral types vary depending on race and socioeconomic status as well as the particular cancer type (cervix versus other). Ultimately, access to preventative care, including widespread pap smear screening for cervical cancer precursors and HPV vaccination, is the answer to eradicating HPV-related disease.

Ancillary